Diagnostic yield of prothrombotic state studies in cryptogenic stroke

Acta Neurologica Scandinavica

Volumn 114, Issue 4, 2006, Pages 250-253

  Belvis R ^a,b   Santamaria A ^a   Marti Fabregas J ^a   Cocho, D ^a   Borrell, M ^a   Fontcuberta, J ^a   Marti Vilalta J L ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Antiphospholipid; Cryptogenic stroke; Leiden; Prothrombin; Prothrombotic state

Indexed keywords

BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR 5 LEIDEN; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; PROTEIN C; VITRONECTIN;

ANTIBODY BLOOD LEVEL; ARTICLE; CLINICAL PRACTICE; DEMOGRAPHY; DIAGNOSTIC TEST; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN DEFICIENCY; RISK ASSESSMENT; STROKE;

ADULT; AGE DISTRIBUTION; AGED; ANTIBODIES, ANTIPHOSPHOLIPID; BLOOD COAGULATION; CARDIOVASCULAR DISEASES; CEREBROVASCULAR ACCIDENT; FACTOR V; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUPUS COAGULATION INHIBITOR; MALE; MIDDLE AGED; MUTATION; PROSPECTIVE STUDIES; PROTEIN C; PROTEIN S; PROTHROMBIN; RISK FACTORS; SEX DISTRIBUTION; STROKE; THROMBOSIS;

EID: 33748374451     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2006.00588.x     Document Type: Article

References (34)

1. GRAU AJ, WEIMAR CH, BUGGLE F et al. on behalf of the German Stroke Data Bank Collaborators. Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German stroke data bank. Stroke 2001;32:2559-66.
2. SOUTO JC, COLL I, LLOBET D et al. The prothrombin 20210A allele is the most prevalent genetic risk factor for venous thromboembolism in the Spanish population. Thromb Haemost 1998;80:366-9.
3. ROSENDAAL FR, DOGGEN CJ, ZIVELIN A et al. Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost 1998;79:706-8.
4. RIDKER PM, HENNEKENS CH, MILETICH JP. G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men. Circulation 1999;99:999-1004.
5. LINDMARKER P, SCHULMAN S, STEN-LINDER M, WIMAN B, EGBERG N, JOHNSSON H. The risk of recurrent venous thromboembolism in carriers and non-carriers of the G1691A allele in the coagulation factor V gene and the G20210A allele in the prothrombin gene. DURAC Trial Study Group. Duration of Anticoagulation. Thromb Haemost 1999;81:684-9.
6. NGUYEN A. Prothrombin G20210A polymorphism and thrombophilia. Mayo Clin Proc 2000;75:595-604.
7. RIDKER PM, HENNEKENS CH, LINDPAINTNER K, STAMPFER MJ, EISENBERG PR, MILETICH JP. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 1995;332:912-7.
8. SOUTO JC, ALMASY L, BORRELL M et al. Genetic susceptibility to thrombosis and its relationship to physiological risk factors: the GAIT study. Genetic analysis of idiopathic thrombophilia. Am J Hum Genet 2000;67:1452-9.
9. REES DC, COX M, CLEGG JB. World distribution of factor V Leiden. Lancet 1995;346:1133-4.
10. BUSHNELL CD, GOLDSTEIN LB. Diagnostic testing for coagulopathies in patients with ischemic stroke. Stroke 2000;31:3067-78.
11. HANKEY GJ, EIKELBOOM JW, VAN BOCKXMEER FM, LOFTHOUSE E, STAPLES N, BAKER RI. Inherited thrombophilia in ischemic stroke and its pathogenic subtypes. Stroke 2001;32:1793-9.
12. JERRARD-DUNNE P, EVANS A, MCGOVERN R et al. Ethnic differences in markers of thrombophilia: implications for the investigation of ischemic stroke in multiethnic populations: the South London Ethnicity and Stroke Study. Stroke 2003;34:1821-6.
13. AUSTIN H, CHIMOWITZ MI, HILL HA et al. Genetics and Stroke in the Young Study Group. Cryptogenic stroke in relation to genetic variation in clotting factors and other genetic polymorphisms among young men and women. Stroke 2002;33:2762-8.
14. SANTAMARÍA A, OLIVER A, BORRELL M et al. Risk of ischemic stroke associated with functional thrombin-activable fibrinolysis inhibitor plasma levels. Stroke 2003;34:2387-91.
15. ADAMS HP JR, BENDIXEN BH, KAPPELLE LJ et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. Stroke 1993;24:35-41.
16. GHARAVI AF, HARRIS EN, ASHERSON ZRA, HUGHES GRV. Anticardiolipin antibodies: isotypes distribution and phospholipid specificity. Ann Rheum Dis 1987;46:1-6.
17. EXNER T, RICHARD A, KRONENBERG H. A sensitive test demonstrating lupus anticoagulant and its behavioural patterns. B J Haematol 1978;40:143-51.
18. SORIA JM, ALMASY L, SOUTO JC et al. Linkage analysis demonstrates that the prothrombin G20210A mutation jointly influences plasma prothrombin levels and risk of thrombosis. Blood 2000;95:2780-5.
19. HABERL RL, BINIASCH O, OTT M, PEINEMANN A, WICK M, KEMPTER B. Infrequency of stroke caused by specific coagulation disorders. Cerebrovasc Dis 1995;5:391-6.
20. BUSHNELL C, SIDDIQI Z, MORGENLANDER JC, GOLDSTEIN LB. Use of specialized coagulation testing in the evaluation of patients with acute ischemic stroke. Neurology 2001;56:624-7.
21. CATTO A, CARTER A, IRELAND H et al. Factor V Leiden gene mutation and thrombin generation in relation to the development of acute stroke. Arterioscler Thromb Vasc Biol 1995;15:783-5.
22. PRESS RD, LIU XY, BEAMER N, COULL BM. Ischemic stroke in the elderly. Role of the common factor V mutation causing resistance to activated protein C. Stroke 1996;27:44-8.
23. CORRAL J, GONZALEZ-CONEJERO R, LOZANO ML, RIVERA J, HERAS I, VICENTE V. The venous thrombosis risk factor 20210 A allele of the prothrombin gene is not a major risk factor for arterial thrombotic disease. Br J Haematol 1997;99:304-7.
24. FERRARESI P, MARCHETTI G, LEGNANI C et al. The heterozygous 20210 G/A prothrombin genotype is associated with early venous thrombosis in inherited thrombophilias and is not increased in frequency in artery disease. Arterioscler Thromb Vasc Biol 1997;17:2418-22.
25. LONGSTRETH WT JR, ROSENDAAL FR, SISCOVICK DS et al. Risk of stroke in young women and two prothrombotic mutations: factor V Leiden and prothrombin gene variant (G20210A). Stroke 1998;29:577-80.
26. MARGAGLIONE M, D'ANDREA G, GIULIANI N et al. Inherited prothrombotic conditions and premature ischemic stroke: sex difference in the association with factor V Leiden. Arterioscler Thromb Vasc Biol 1999;19:1751-6.
27. VOETSCH B, DAMASCENO BP, CAMARGO EC et al. Inherited thrombophilia as a risk factor for the development of ischemic stroke in young adults. Thromb Haemost 2000;83:229-33.
28. SZOLNOKI Z, SOMOGYVARI F, KONDACS A, SZABO M, FODOR L. Evaluation of the interactions of common genetic mutations in stroke subtypes. J Neurol 2002;249:1391-7.
29. MADONNA P, DE STEFANO V, COPPOLA A et al. Hyperhomocysteinemia and other inherited prothrombotic conditions in young adults with a history of ischemic stroke. Stroke 2002;33:51-6.
30. EMMERICH J, POIRIER O, EVANS A et al. Myocardial infarction, Arg 506 to Gln factor V mutation, and activated protein C resistance. Lancet 1995;345:321.
31. ROSENDAAL FR, SISCOVICK DS, SCHWARTZ SM, PSATY BM, RAGHUNATHAN TE, VOS HL. A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young women. Blood 1997;90:1747-50.
32. DOGGEN CJ, CATS VM, BERTINA RM, ROSENDAAL FR. Interaction of coagulation defects and cardiovascular risk factors: increased risk of myocardial infarction associated with factor V Leiden or prothrombin 20210A. Circulation 1998;97:1037-41.
33. BUSHNELL C, GOLDSTEIN LB. Screening for hypercoagulable syndromes following stroke. Curr Atheroscler Rep 2003;5:291-8.
34. SANTAMARÍA A, MATEO J, TIRADO I et al. Homozigosity of the T allele of the 46C-> T polymorphism in the F12 gene is a risk factor for ischemic stroke in the Spanish population. Stroke 2004;35:1795-9.